Adhera Therapeutics is a clinical stage biopharmaceutical company focused on identifying advanced drug candidates that may qualify for accelerated developmental pathways. The Company has recently licensed two drug candidates, MLR-1019 and MLR-1023, from the Melior Discovery family of companies. Adhe... Adhera Therapeutics is a clinical stage biopharmaceutical company focused on identifying advanced drug candidates that may qualify for accelerated developmental pathways. The Company has recently licensed two drug candidates, MLR-1019 and MLR-1023, from the Melior Discovery family of companies. Adhera is developing MLR-1023 (tolimidone) as a new drug for Type I diabetes with a focus on C-peptide positive patients. MLR-1023, a lyn kinase activator, has demonstrated exceptional clinical safety and tolerability in over 700 patients in Phase 2a and Phase 2b Type 2 diabetes studies. MLR-1019 (armesocarb) is a new class of drug for Parkinson's Disease (PD) and represents the only drug to address both movement and non-movement symptoms of PD. Armesocarb is the active enantiomer in mesocarb, a drug marketed in Europe for 37 years for various psychiatric and central nervous system indications. In addition to advancing both drug candidates in Phase 2 clinical trials, the Company remains active in exploring other advanced drug development opportunities while maintaining its legacy assets, including CEQ508, an oral delivery of small interfering RNA (siRNA) against beta-catenin, to suppress polyps in the precancerous syndrome and orphan indication Familial Adenomatous Polyposis (FAP). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0.0001 | 0 | 0 | 0 | CS |
4 | -0.0023 | -95.8333333333 | 0.0024 | 0.0024 | 0.0001 | 17979 | 0.00010431 | CS |
12 | -0.0089 | -98.8888888889 | 0.009 | 0.015 | 0.0001 | 25017 | 0.00763199 | CS |
26 | -0.0119 | -99.1666666667 | 0.012 | 0.017 | 0.0001 | 66876 | 0.00948789 | CS |
52 | -0.0189 | -99.4736842105 | 0.019 | 0.0475 | 0.0001 | 148371 | 0.0148714 | CS |
156 | -0.152 | -99.9342537804 | 0.1521 | 1.09 | 0.0001 | 90986 | 0.06109867 | CS |
260 | -0.0799 | -99.875 | 0.08 | 1.09 | 0.0001 | 87434 | 0.11294989 | CS |
Symbol | Price | Vol. |
---|---|---|
RONNRonn Motor Group Inc (PK) | $ 0.0007 (-12.50%) | 153.51M |
GRLFGreen Leaf Innovations Inc (PK) | $ 0.00015 (50.00%) | 136.59M |
HMBLHUMBL Inc (PK) | $ 0.00015 (-25.00%) | 92.93M |
AITXArtificial Intelligence Technology Solutions Inc (PK) | $ 0.0028 (-3.45%) | 87.39M |
SINCSincerity Applied Materials Holdings Corporation (PK) | $ 0.0012 (-14.29%) | 75.92M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.